Diaceutics PLC Valuation
| DIUXF Stock | USD 1.67 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Diaceutics PLC shows a prevailing Real Value of $1.52 per share. The current price of the firm is $1.67. Our model computes the value of Diaceutics PLC from reviewing the firm fundamentals such as Current Valuation of 54.7 M, operating margin of 0 %, and Profit Margin of 0.01 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Diaceutics PLC's price fluctuation is very risky at this time. Calculation of the real value of Diaceutics PLC is based on 3 months time horizon. Increasing Diaceutics PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Diaceutics pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Diaceutics PLC. Since Diaceutics PLC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Diaceutics Pink Sheet. However, Diaceutics PLC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.67 | Real 1.52 | Hype 1.67 | Naive 1.57 |
The real value of Diaceutics Pink Sheet, also known as its intrinsic value, is the underlying worth of Diaceutics PLC Company, which is reflected in its stock price. It is based on Diaceutics PLC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Diaceutics PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Diaceutics PLC helps investors to forecast how Diaceutics pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Diaceutics PLC more accurately as focusing exclusively on Diaceutics PLC's fundamentals will not take into account other important factors: About Diaceutics PLC Valuation
The pink sheet valuation mechanism determines Diaceutics PLC's current worth on a weekly basis. Our valuation model uses a comparative analysis of Diaceutics PLC. We calculate exposure to Diaceutics PLC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Diaceutics PLC's related companies.Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom. Diaceutics Plc is traded on OTC Exchange in the United States.
8 Steps to conduct Diaceutics PLC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Diaceutics PLC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Diaceutics PLC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Diaceutics PLC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Diaceutics PLC's revenue streams: Identify Diaceutics PLC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Diaceutics PLC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Diaceutics PLC's growth potential: Evaluate Diaceutics PLC's management, business model, and growth potential.
- Determine Diaceutics PLC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Diaceutics PLC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Diaceutics PLC Growth Indicators
Investing in growth stocks can be very risky. If the company such as Diaceutics PLC does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 84.1 M | |
| Forward Price Earnings | 25.3165 | |
| Retained Earnings | 4.1 M |
Complementary Tools for Diaceutics Pink Sheet analysis
When running Diaceutics PLC's price analysis, check to measure Diaceutics PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diaceutics PLC is operating at the current time. Most of Diaceutics PLC's value examination focuses on studying past and present price action to predict the probability of Diaceutics PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diaceutics PLC's price. Additionally, you may evaluate how the addition of Diaceutics PLC to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |